Literature DB >> 20006737

Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.

Sardarpasha Sheikpranbabu1, Haribalaganesh Ravinarayanan, Banumathi Elayappan, Park Jongsun, Sangiliyandi Gurunathan.   

Abstract

Increased vascular permeability associated with retinal vascular leakage is known to occur in patients with diabetes, and contributes to endothelial barrier dysfunction. The purpose of this study was to examine the effect of pigment epithelium-derived factor (PEDF) on signaling cascade in porcine retinal endothelial cells (PREC) related to permeability and angiogenesis induced by vascular endothelial growth factor (VEGF)-and interleukin-1beta (IL-1beta). PREC were exposed to VEGF, IL-1beta and PEDF at different concentrations, and in vitro permeability was assessed by solute flux assay using 70-kDa RITC-dextran. Angiogenic assays such as proliferation, migration and tube formation were determined by MTT, wound-scratch method and on-gel assay system respectively. To explore the signaling pathways behind VEGF-and IL-1beta-induced PREC permeability, an inhibitor assay was carried out using PP2, a Src kinase inhibitor. Further, Src activity was assessed by transient transfection assay using constitutively active (CA) and dominant negative (DN) Src mutants. We report that VEGF-and IL-1beta-stimulates permeability, in a dose and time-dependent manner and PEDF inhibits the VEGF-and IL-1beta-induced PREC permeability. In addition, PEDF inhibits the VEGF-and IL-1beta-induced endothelial cell proliferation, migration and tube formation. In addition, overexpression of DN Src blocked both VEGF-and IL-1beta-stimulation of permeability, proliferation and migration, while overexpression of CA Src overpowers the inhibitory action of PEDF on permeability, proliferation and migration. These results demonstrate that PEDF may inhibit the VEGF-and IL-1beta-induced permeability and angiogenesis via Src-dependent pathway. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006737     DOI: 10.1016/j.vph.2009.12.002

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  10 in total

1.  Targeting therapy of choroidal neovascularization by use of polypeptide- and PEDF-loaded immunoliposomes under ultrasound exposure.

Authors:  Tao Li; Ming Zhang; Yong Han; Hong Zhang; Lingjuan Xu; Yan Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

2.  Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells.

Authors:  Chun-Ming Li; Wei Li; Xiao-Yong Man; Jiong Zhou; Jia-Qi Chen; Sui-Qing Cai; Min Zheng
Journal:  Mol Biol Rep       Date:  2010-09-21       Impact factor: 2.316

3.  Targeting Neovascularization in Ischemic Retinopathy: Recent Advances.

Authors:  Mohamed Al-Shabrawey; Mohamed Elsherbiny; Julian Nussbaum; Amira Othman; Sylvia Megyerdi; Amany Tawfik
Journal:  Expert Rev Ophthalmol       Date:  2013-06

4.  Adenoviral E4 gene stimulates secretion of pigmental epithelium derived factor (PEDF) that maintains long-term survival of human glomerulus-derived endothelial cells.

Authors:  Marina Jerebtsova; Namita Kumari; Yuri Obuhkov; Sergei Nekhai
Journal:  Mol Cell Proteomics       Date:  2012-08-21       Impact factor: 5.911

5.  Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia.

Authors:  Anne Chetty; Michelle Bennett; Linh Dang; Daisy Nakamura; Gong-Jie Cao; Sana Mujahid; MaryAnn Volpe; Ira Herman; S Patricia Becerra; Heber C Nielsen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

6.  Pigment epithelium derived factor inhibits the growth of human endometrial implants in nude mice and of ovarian endometriotic stromal cells in vitro.

Authors:  Yanmei Sun; Xuan Che; Libo Zhu; Mengdan Zhao; Guofang Fu; Xiufeng Huang; Hong Xu; Fuqiang Hu; Xinmei Zhang
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  PEDF regulates vascular permeability by a γ-secretase-mediated pathway.

Authors:  Jun Cai; Lin Wu; Xiaoping Qi; Sergio Li Calzi; Sergio Caballero; Lynn Shaw; Qing Ruan; Maria B Grant; Michael E Boulton
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

8.  VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis.

Authors:  Li Sun; Quan Yuan; Ning Cao; Wei Guo; Li Yao; Jiang-Min Feng; Jian-Fei Ma; Li-Ning Wang
Journal:  ScientificWorldJournal       Date:  2014-08-11

9.  Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization.

Authors:  Feng Zhao; Wenlei Fei; Zhouyue Li; Hanyang Yu; Lei Xi
Journal:  J Diabetes Res       Date:  2022-04-22       Impact factor: 4.061

10.  Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury.

Authors:  Nianting Tong; Zhenzhen Zhang; Wei Zhang; Yating Qiu; Yuanyuan Gong; Lili Yin; Qinghua Qiu; Xingwei Wu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.